Instinct Bio Technical Company Holdings Inc. (BIOT) Cash Flow Statement

NASDAQ: BIOTOperating cash, capex, free cash flow and buybacks.

Where BIOT’s cash came from and went, FY2024

November 30, 2024 · U.S. dollars
Cash from operations
$589,724
Capital expenditures
$26,788
1.0% of revenue
Free cash flow
$562,936
20.4% margin
Returned to shareholders
—
Change in cash
$293,549
cash at year-end $512,446
Cash from operations: $589,724Cash from operations$589,724Debt repayment: $266,093Debt repayment$266,093 · 45%Capital expenditures: $26,788Capital expenditures$26,788 · 5%Added to cash: $293,549Added to cash$293,549 · 50%Other financing: $3,294Other financing$3,294 · 1%$589,724
Cash from operations
$589,724
Capital expenditures
−$26,788
Net borrowing (repayment)
−$266,093
Other financing
−$3,294
Change in cash
$293,549

Drawn to scale: where the cash came from and how it was used. Hover for values.

BIOT operating cash flow, capex and free cash flow

Operating cash flowCapital expendituresFree cash flowFCF margin (right axis)

BIOT cash flow trends, FY2023–FY2024

Instinct Bio Technical Company Holdings Inc. cash flow trends
MetricTrendThenLatestChange
Operating cash flow−$977,786FY2023$589,724FY2024—
Capital expenditures$70,310FY2023$26,788FY2024−61.9%/yr
Free cash flow−$1.0MFY2023$562,936FY2024—
Free cash flow margin−30.5%FY202320.4%FY2024+50.9 pts
Operating cash flow / net income−1.79FY20237.90FY2024+9.69
Dividends paid$0FY2023$0FY2024—
Capex / revenue2.0%FY20231.0%FY2024−1.1 pts

Change is the average annual growth (CAGR) or the difference between the first and latest year.

BIOT cash flow by activity

OperatingInvestingFinancingChange in cash

BIOT net income vs operating cash flow

Net incomeOperating cash flow

Operating cash flow above net income usually means earnings are backed by cash (depreciation and stock-based pay are non-cash expenses).

BIOT cash flow statement

Instinct Bio Technical Company Holdings Inc. annual cash flow statement
FY2024FY2023
Operating activities
Net income$74,657$544,876
Depreciation & amortization$236,878$216,703
Change in working capital−$136,652−$787,392
Other non-cash items$414,841−$951,973
Cash from operating activities$589,724−$977,786
Investing activities
Capital expenditures−$26,788−$70,310
Financing activities
Dividends paid$0$0
Net borrowing (repayment)−$266,093$22,316
Shares issued$0$0
Other financing−$3,294−$3,536
Cash from financing activities−$269,387$18,780
Summary
Net change in cash$293,549−$1.0M
Cash at end of period$512,446$240,380
Free cash flow$562,936−$1.0M
Free cash flow margin20.4%−30.5%
Capex / revenue1.0%2.0%
Operating cash flow / net income7.90−1.79

Negative numbers are cash paid out. Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported; data from EODHD.

BIOT cash generation

In fiscal 2024 (ended November 30, 2024), Instinct Bio Technical generated $0.6 million of cash from operations and spent $0.0 million on capital expenditures, leaving free cash flow of $0.6 million, 20.4% of revenue. Cash and equivalents rose by $0.3 million over the year.

Related: BIOT income statement, BIOT balance sheet. See the BIOT stock overview for the latest quote and news.

BIOT cash flow FAQ

What is Instinct Bio Technical's free cash flow?

Instinct Bio Technical's free cash flow was $0.6 million in fiscal 2024: $0.6 million of operating cash flow minus $0.0 million of capital expenditures It was -$1.0 million a year earlier..

How much cash does Instinct Bio Technical generate from operations?

Instinct Bio Technical generated $0.6 million of cash from operating activities in fiscal 2024, 7.90 times its net income of $0.1 million.

How much does Instinct Bio Technical spend on capital expenditures?

Instinct Bio Technical spent $0.0 million on capital expenditures in fiscal 2024, 1.0% of revenue, compared with $0.1 million the year before.

Household & Personal Products: cash flow